Over the past several decades, much of the developed world has experienced a sustained reduction in age-standardized stroke mortality and morbidity rates.1 For many of these countries, these improvements have translated into declines in absolute stroke mortality and morbidity as well. For example, stroke had been the third-leading cause of death in the United States for >70 years until 2008, when it became the fourth leading cause of death.2,3 Just 5 years later, stroke became the fifth leading cause of death4—a drop that reflected the >60% decline in the age-adjusted mortality rate from stroke over just the past few decades.5,6 For most other developed countries, the recent experience and outlook for stroke has been similar.1,7 Over the past 20 years, high-income countries as a group have experienced a 13% decline (95% confidence interval, 6–18%) in the age-standardized incidence rate, a 37% decline (95% confidence interval 19–39%) in the age-standardized mortality rate, and a 21% decline (95% confidence interval, 10–27%) in the age-standardized disease burden from ischemic stroke as measured in disability-adjusted life year (DALY) loss rates.8,9 (DALYs are a summary measure of disease burden that combines the impact of years of healthy life lost caused by premature death with the effect of long-term disability on quality of life over time.) For hemorrhagic stroke, there have been similar improvements in these indicators over the same period.8,10 However, the global outlook for the total disease burden from stroke is a bit more humbling. In 2013, an estimated 6.4 million deaths (11.8% of all deaths) were caused by stroke, and stroke remained the third-leading cause of years-of-potential-life lost worldwide (Table 1).1,8,11,12 Between 1990 and 2010, the absolute incidence of …